the impact of secondary-type mutations in npm1-mutated aml
Published 2 years ago • 400 plays • Length 1:45Download video MP4
Download video MP3
Similar videos
-
2:19
secondary-type mutations do not impact the favorable prognosis in npm1-mutated aml
-
3:18
the impact of secondary aml mutations on the prognosis of patients with npm1-mutated aml
-
3:07
the impact of blast enumeration & co-occurring myelodysplasia-related mutations in npm1-mutated aml
-
1:21
the prognostic impact of secondary-type mutations in patients with favorable risk aml
-
1:38
value of mrd in patients with npm1-mutated aml
-
1:39
the impact of complex karyotype on post-transplant outcomes in npm1-mutated aml
-
1:41
the emerging role of menin inhibitors in the treatment of npm1-mutated and kmt2a-rearranged r/r aml
-
4:30
which gene mutations are categorized as low, intermediate and high risk aml? #aml
-
3:47
splice-site mutations
-
4:34
the genetics of acute myeloid leukemia (aml)
-
4:51
the impact of idh mutated clones in npm1 aml
-
4:43
treatment of npm1-mutated aml: intensive standard treatment
-
3:55
ziftomenib: a menin inhibitor for r/r npm1-mutated aml
-
1:38
lba: komet-001 - ziftomenib monotherapy in r/r npm1-mutated aml
-
1:56
ngs vs flow cytometry for mrd assessment in npm1-mutated aml
-
3:10
impact of splicing factor mutations on aml treatment
-
3:19
an overview of novel treatment approaches in tp53-mutated aml
-
3:21
the prognostic impact of flt3-itd and flt3-tkd in npm1-mutated aml
-
1:15
outcomes of non-intensive chemotherapy differ for idh1 and idh2-mutated aml
-
1:35
novel mutations in pv & the importance of understanding their role in disease initiation
-
1:20
impact of tp53 mutations on outcomes in myelofibrosis
-
1:32
novel treatment combinations for flt3-mutated aml